EUVIMEDEUVIMED entdecken
Vergleichsstudie

Comparative efficacy of two different subthreshold yellow laser treatments for chronic central serous chorioretinopathy

O Artunay, M Ozbek, S Pehlivanoglu

Journal Français d'Ophtalmologie · 2025

DOI: 10.1016/j.jfo.2025.104652 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal Français d'Ophtalmologie, 2025. Verfasst von O Artunay und 2 weiteren Autor:innen. Beteiligte Einrichtung: Ophthalmology Department, Beyoglu Eye Training and Research Hospital, Bereketzade Cami Sk. No: 2, 34421 Istanbul, Turkey. Hauptthemen laut MEDLINE: Central Serous Chorioretinopathy, Laser Coagulation, Laser Therapy. Die Arbeit nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To investigate and compare the anatomic and functional outcomes in patients with chronic central serous chorioretinopathy (cCSC) who have undergone subthreshold laser therapy using either the Navigated Microsecond Laser (nMSL) or Endpoint Management™ (EpM) system. METHODS: This retrospective study evaluated 80 eyes (78 patients) with cCSC. Patients were divided into two groups: nMSL treatment (n=39, group 1) and the EpM procedure (n=41, group 2). The primary outcomes at 6 months were changes in best-corrected visual acuity (BCVA) and central macular thickness (CMT), along with the rate of complete subretinal fluid (SRF) resolution. RESULTS: Group 1 demonstrated a significantly greater improvement in BCVA compared to group 2 at both 3 and 6 months post-treatment (P=0.006 and P=0.013, respectively). Both groups exhibited a statistically significant decrease in mean CMT. At 6 months, a higher proportion of patients in group 1 achieved complete resolution of SRF compared to group 2 (76.9% vs. 61.0%). CONCLUSION: According to our findings, navigated MSL is highly effective in terms of visual outcomes and retinal morphology. EpM is also effective in decreasing SRF in cCSC patients. In cCSC patients, nMSL therapy may be a more effective and safe approach for restoring macular anatomy and visual outcomes than EpM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Central Serous ChorioretinopathyLaser CoagulationLaser TherapyHumansMaleFemaleChronic DiseaseMiddle AgedRetrospective StudiesTreatment OutcomeAdultVisual AcuityTomography, Optical CoherenceAged

Stichwörter der Autor:innen

Central serous chorioretinopathyChoriorétinopathie séreuse centraleLaser jaune à seuil inférieurLaser microseconde naviguéLiquide sous-rétinienNavigated Microsecond LaserSubretinal fluidSubthreshold yellow laser

Autor:innen und Institutionen

  • Ophthalmology Department, Beyoglu Eye Training and Research Hospital, Bereketzade Cami Sk. No: 2, 34421 Istanbul, Turkey.
  • Ophthalmology Department, Beyoglu Eye Training and Research Hospital, Bereketzade Cami Sk. No: 2, 34421 Istanbul, Turkey. Electronic address: drmerveyalcin@gmail.com.

Zitieren

APA

Artunay, O., Ozbek, M., & Pehlivanoglu, S. (2025). Comparative efficacy of two different subthreshold yellow laser treatments for chronic central serous chorioretinopathy. Journal Français d'Ophtalmologie. https://doi.org/10.1016/j.jfo.2025.104652

Vancouver

Artunay O, Ozbek M, Pehlivanoglu S. Comparative efficacy of two different subthreshold yellow laser treatments for chronic central serous chorioretinopathy. Journal Français d'Ophtalmologie. 2025. doi:10.1016/j.jfo.2025.104652

BibTeX
@article{Artunay2025,
  author = {Artunay, O and Ozbek, M and Pehlivanoglu, S},
  title = {Comparative efficacy of two different subthreshold yellow laser treatments for chronic central serous chorioretinopathy},
  journal = {Journal Français d'Ophtalmologie},
  year = {2025},
  doi = {10.1016/j.jfo.2025.104652}
}
Kostenlos starten →